Substituted piperidines

Details Substituted piperidines Substituted piperidines

2006-06-20

2006-06-20

Chang, Celia (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S318000, C514S326000, C546S187000, C546S193000, C546S208000

Reexamination Certificate

active

07064135

ABSTRACT:
A novel class of substituted piperidines, pharmaceutical compositions comprising them and use thereof in the treatment of diseases and disorders related to the histamine H3 receptor. More particularly, the compounds are useful for the treatment of diseases and disorders in which an interaction with the histamine H3 receptor is beneficial.

REFERENCES:
patent: 3337551 (1967-08-01), Faith
patent: 4943573 (1990-07-01), Meanwell
patent: 2001/0039286 (2001-11-01), Dinnell et al.
patent: 0091241 (1983-03-01), None
patent: 0426180 (1990-10-01), None
patent: 0978512 (1998-07-01), None
patent: 1008346 (2000-06-01), None
patent: 41019506 (1964-07-01), None
patent: WO 83/03410 (1983-10-01), None
patent: WO 84/01576 (1984-04-01), None
patent: WO 84/03089 (1984-08-01), None
patent: WO 94/20473 (1994-09-01), None
patent: WO 97/17345 (1997-05-01), None
patent: WO 97/43282 (1997-11-01), None
patent: WO 97/43292 (1997-11-01), None
patent: WO 99/42458 (1999-08-01), None
patent: WO 99/48491 (1999-09-01), None
patent: WO 00/06254 (2000-02-01), None
patent: WO 01/21206 (2001-03-01), None
Chemcas 2003:1930211 Interchem intermediates, RN 496772-78-2 (2002).
Greengrass et al. “N-N'-(5-amino-4 . . . ” CA 121:83064 (1994).
Bowen et al. “Heterocycliylpiperidines and . . . ” CA 121:300770 (1994).
Matsuhisa et al. “Preparation of . . . ” Ca 122:31580 (1995).
Ishihara et al. “Preparation of benzoaromatic . . . ” CA 136:5926 (2001).
Kataoka et al. “Preparation of pyrrolopyrimidine . . . ” Ca 139:214482 (2003).
Ganellin et al., Arch. Pharm. Pharm. Med. Chem., vol. 331, pp. 395-404 (1998).
Linney et al., Journal of Medicinal Chemistry, vol. 43, No. 12, pp. 2363-2370 (2000).
Lovenberg et al., Molecular Pharmacology, vol. 55, pp. 1101-1107 (1999).
Meanwell et al., J. Med. Chem. vol. 35, pp. 2688-2696 (1992).
Morisset et al., Nature, vol. 408, pp. 860-864 (2000).
Rehse et al., Arch. Pharm. (Weinheim), vol. 312, pp. 670-681 (1979)—Abstract.
Singh et al., Progress in Drug Research, vol. 45, pp. 108-165 (1995).
Stark et al., Drugs of the Future, vol. 21, No. 5, pp. 507-520 (1996).
Tiwari et al., Drug Design and Discovery, vol. 12, pp. 249-258 (1995).
Tozer et al., Exp. Opin. Ther. Patents, vol. 10, No. 7, pp. 1045-1055 (2000).
Walczynski et al., Arch. Pharm. Pharm. Med. Chem., vol. 332, pp. 389-398.
Walczynski et al., Elsevier, II Farmaco, vol. 54, pp. 684-694 (1999).
Weinstock et al., Journal of Pharmaceutical Sciences, vol. 70, No. 8, pp. 956-959 (1981).

Affiliated with

Also associated with

Rating

Substituted piperidines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted piperidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted piperidines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3698568